Diagnosis, Biomarkers, and Treatment of Metabolic Disorders
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 763
Special Issue Editor
Interests: lysosomal storage diseases; neurodegenerative diseases; genomics; genetic engineering; cancer biomarkers; metabolism
Special Issue Information
Dear Colleagues,
Diagnosis, Biomarkers, and Treatment of Metabolic Disorders is a Special Issue published in the Journal Diagnostics (ISSN 2075-4418) which is an international scholarly open-access journal. It publishes original research articles and comprehensive reviews, and there is no restriction on the maximum length of the papers. Our aim is to encourage healthcare professionals and scientists to publish their experimental, theoretical, and original research related to any aspects of metabolic diseases in humans or animal models in as much detail as possible. Full experimental and/or methodological details must be provided for research articles. This includes clinical, experimental, genetic, biochemical, methodological, theoretical, ethical, and counseling aspects.
The scope of this Special Issue includes as follows:
- Metabolic diseases;
- Treatment and therapies of metabolic diseases;
- Diagnosis of metabolic diseases;
- Biomarkers of metabolic diseases;
- Inherited metabolic diseases;
- Inborn errors of metabolism;
- Neurodegeneration in metabolic diseases;
- Lysosomal storage diseases;
- Pathogenesis of metabolic diseases;
- Artificial intelligence and machine learning in inherited metabolic diseases;
- Functional genomics of metabolic diseases.
Welcome to submit your related work to the Special Issue.
Dr. Elena-Raluca Nicoli
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolic disorders
- diagnosis
- treatment
- biomarkers